B. Khairullin

发表

Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies

S. Olsen, G. Renukaradhya, K. Tabynov, 2021, Frontiers in Cellular and Infection Microbiology.

Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection

B. Ferko, I. Kuznetsova, K. Tabynov, 2014, Virology Journal.

Comparison of Different Methods of Purification and Concentration in Production of Influenza Vaccine

K. Tabynov, S. Ryskeldinova, B. Khairullin, 2017, Bulletin of Experimental Biology and Medicine.

Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector.

M. Wolschek, M. Stukova, O. Kiselev, 2014, The Journal of general virology.

Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan

M. Stukova, M. Orynbayev, M. Kassenov, 2020, Human vaccines & immunotherapeutics.

Assessment of the immunogenicity and protective effectiveness of Refluvac® in mice challenged with a Pandemic A/H1N1 influenza

M. Kassenov, B. Khairullin, A. Sansyzbay, 2018 .

Immunogenicity of the inactivated oil emulsion influenza A (H5N1) vaccine in chickens.

K. Tabynov, B. Khairullin, S. Mamadaliyev, 2010 .

Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine

M. Kassenov, G. Renukaradhya, K. Tabynov, 2019, Archives of Virology.

Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization

B. Khairullin, A. Sansyzbay, Y. Bulatov, 2017, Archives of Virology.

Safety and immunogenicity of the novel seasonal preservative‐ and adjuvant‐free influenza vaccine: Blind, randomized, and placebo‐controlled trial

Zhanna Buzitskaya, M. Stukova, M. Kassenov, 2018, Journal of medical virology.

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19

M. Orynbayev, M. Kassenov, K. Shorayeva, 2022, Human vaccines & immunotherapeutics.

Mechanical Transmission of Lumpy Skin Disease Virus by Stomoxys spp. (Stomoxys calsitrans, Stomoxys sitiens, Stomoxys indica), Diptera: Muscidae

K. Sultankulova, M. Orynbayev, P. White, 2020, Animals : an open access journal from MDPI.

Goatpox virus (G20-LKV) vaccine strain elicits a protective response in cattle against lumpy skin disease at challenge with lumpy skin disease virulent field strain in a comparative study.

M. Orynbayev, K. Zakarya, B. Khairullin, 2020, Veterinary microbiology.

Lumpy skin disease in Kazakhstan

R. Kock, K. Sultankulova, M. Orynbayev, 2021, Tropical animal health and production.

Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters

Y. Burashev, K. Sultankulova, M. Orynbayev, 2021, bioRxiv.

Immunogenic and protective properties of the first kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in Ferrets

K. Tabynov, S. Ryskeldinova, Y. Kozhamkulov, 2012, Virologica Sinica.

Comparison of Different Methods of Purification and Concentration in Production of Influenza Vaccine

K. Tabynov, S. Ryskeldinova, B. Khairullin, 2017, Bulletin of experimental biology and medicine.

Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine

M. Kassenov, G. Renukaradhya, K. Tabynov, 2019, Archives of Virology.

A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies.

M. Stukova, B. Khairullin, A. Shurygina, 2022, Drug research.

An Inactivated, Adjuvanted Whole Virion Clade 2.2 H5N1 (A/Chicken/Astana/6/05) Influenza Vaccine Is Safe and Immunogenic in a Single Dose in Humans

M. Sergeeva, M. Stukova, O. Kiselev, 2013, Clinical and Vaccine Immunology.

Avian influenza virus H 5 N 1 subtype A diagnosed in sick and dead wild and domestic birds in Pavlodar oblast, Republic of Kazakhstan

K. Tabynov, Zhailaubay Kydyrbayev, Y. Kozhamkulov, 2007 .

Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up

M. Stukova, Y. Burashev, K. Sultankulova, 2022, eClinicalMedicine.

Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan

M. Sergeeva, M. Stukova, K. Sultankulova, 2021, EClinicalMedicine.

Preliminary Assessment of Safety and Immunogenicity of an Inactivated Whole-Virion Vaccine against Influenza А (H1N1) Pdm09 Containing Aluminum Hydroxide Adjuvant: A Randomized, Blinded Phase I Clinical

M. Stukova, O. Kiselev, K. Tabynov, 2013 .

Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization

B. Khairullin, A. Sansyzbay, Y. Bulatov, 2017, Archives of Virology.

Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis

M. Stukova, M. Kassenov, K. Vasilyev, 2023, International journal of molecular sciences.

Influenza monitoring among birds in Kostanaiskaya Oblast, Republic of Kazakhstan.

S. Ryskeldinova, Zhailaubay Kydyrbayev, B. Khairullin, 2010 .

Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection

B. Ferko, K. Tabynov, S. Ryskeldinova, 2014, Virology Journal.

Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults

M. Stukova, M. Kassenov, B. Khairullin, 2018, Human vaccines & immunotherapeutics.

Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector.

M. Wolschek, M. Stukova, O. Kiselev, 2014, The Journal of general virology.